five

Crystal Structure of SOS1 with MRTX0902, a Potent and Selective Inhibitor of the SOS1:KRAS Protein-Protein Interaction

收藏
Protein Data Bank Japan2023-10-18 更新2026-04-19 收录
下载链接:
https://pdbj.org/mine/summary/7ukr
下载链接
链接失效反馈
官方服务:
资源简介:
Crystal Structure of SOS1 with MRTX0902, a Potent and Selective Inhibitor of the SOS1:KRAS Protein-Protein Interaction Descriptor: 2-methyl-3-[(1R)-1-{[4-methyl-7-(morpholin-4-yl)pyrido[3,4-d]pyridazin-1-yl]amino}ethyl]benzonitrile, Son of sevenless homolog 1 Authors: Gunn, R.J, Lawson, J.D, Ketcham, J.M, Marx, M.A. Deposit date: 2022-04-01 Release date: 2022-07-27 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction. J.Med.Chem., 65, 2022

SOS1与MRTX0902共晶结构:MRTX0902是一种强效且选择性靶向SOS1:KRAS蛋白-蛋白相互作用的抑制剂 描述符:2-甲基-3-[(1R)-1-{[4-甲基-7-(4-吗啉基)吡啶并[3,4-d]哒嗪-1-基]氨基}乙基]苯甲腈,Son of Sevenless同源物1(SOS1) 作者:Gunn, R.J.、Lawson, J.D.、Ketcham, J.M.、Marx, M.A. 提交日期:2022-04-01 发布日期:2022-07-27 最后修改日期:2023-10-18 实验方法:X射线衍射(2.5 Å) 引用文献:《MRTX0902的设计与发现:一种强效、选择性、可透过血脑屏障且口服生物可利用的SOS1:KRAS蛋白-蛋白相互作用抑制剂》,《药物化学杂志》,2022年,第65卷
创建时间:
2022-04-01
二维码
社区交流群
二维码
科研交流群
商业服务